Enzymatica develops solutions that support the body's own defenses against virus, irritants and microorganisms.
the science
that protects
press
releases
All press releases
- June 23rd 2022 - Regulatory press releasesColdZyme blocks omicron virus – according to new research
- June 16th 2022 - Regulatory press releasesEnzymatica signs loan agreement with major shareholders
- April 28th 2022 - Regulatory press releasesBulletin from Annual General Meeting of Enzymatica AB (publ) on 28 April 2022
financial
reports
All reports
- April 28th 2022Interim report Q1/2022: Our financial targets remain in place
- March 31st 2022Company presentation 2021
- February 17th 2022Year-end report: Clear signs of favourable market trends after a challenging 2021
financial
calendar
All events
- July 19th 2022Interim Report January - June 2022
- November 2nd 2022Interim report January -September 2022
enzyme science
Research has shown that in some cold-adapted marine organisms such as cod there is an enzyme with good protective properties.
research& development
Enzymatica focuses on product development based on the tested and patented barrier technology used in the common cold product ColdZyme.
Find out more
sustainability
Health and well-being constitute the foundation of our company, and we want to use resources wisely and sustainably.
Find out more